- Home
- ARBEW vs MRK Comparison
ARBEW vs MRK Comparison
Compare ARBEW & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARBEW
- MRK
- Stock Information
- Founded
- ARBEW 2015
- MRK 2000
- Country
- ARBEW Israel
- MRK United States
- Employees
- ARBEW 144
- MRK N/A
- Industry
- ARBEW EDP Services
- MRK Biotechnology: Pharmaceutical Preparations
- Sector
- ARBEW Technology
- MRK Health Care
- Exchange
- ARBEW Nasdaq
- MRK Nasdaq
- Market Cap
- ARBEW N/A
- MRK 218.8B
- IPO Year
- ARBEW N/A
- MRK N/A
- Fundamental
- Price
- ARBEW $0.37
- MRK $83.79
- Analyst Decision
- ARBEW
- MRK Buy
- Analyst Count
- ARBEW 0
- MRK 15
- Target Price
- ARBEW N/A
- MRK $105.14
- AVG Volume (30 Days)
- ARBEW 32.4K
- MRK 13.6M
- Earning Date
- ARBEW 03-05-2025
- MRK 10-30-2025
- Dividend Yield
- ARBEW N/A
- MRK 3.86%
- EPS Growth
- ARBEW N/A
- MRK 20.41
- EPS
- ARBEW N/A
- MRK 6.49
- Revenue
- ARBEW $768,000.00
- MRK $63,616,000,000.00
- Revenue This Year
- ARBEW N/A
- MRK $1.84
- Revenue Next Year
- ARBEW N/A
- MRK $5.24
- P/E Ratio
- ARBEW N/A
- MRK $12.94
- Revenue Growth
- ARBEW N/A
- MRK 1.82
- 52 Week Low
- ARBEW $0.13
- MRK $73.31
- 52 Week High
- ARBEW $1.25
- MRK $111.20
- Technical
- Relative Strength Index (RSI)
- ARBEW 59.35
- MRK 47.51
- Support Level
- ARBEW $0.28
- MRK $86.20
- Resistance Level
- ARBEW $0.45
- MRK $88.24
- Average True Range (ATR)
- ARBEW 0.07
- MRK 2.27
- MACD
- ARBEW 0.00
- MRK -0.23
- Stochastic Oscillator
- ARBEW 49.48
- MRK 44.37
About ARBEW Arbe Robotics Ltd. Warrant
Arbe Robotics Ltd is a provider of 4D Imaging Radar solutions enabling driver-assist systems while paving the way for fully autonomous driving. It is a research and development company in the field of chips for Advanced radar systems, which are mainly intended to be used as Advanced Driver Assistance Systems (ADAS) adapted for autonomous vehicles as well as for non-automotive uses. Its geographical segments include Sweden, China, Germany, Hong Kong, USA, Israel, Switzerland, Italy, and others.
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).